NewcelX partners with Eledon to develop diabetes treatment
Go back to NewcelX partners with Eledon to develop diabetes treatment| (NASDAQ: ELDN) | Delayed: 2.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.78 | 52 Week High | $ | |||
| Open | $2.82 | 52 Week Low | $ | |||
| Day High | $2.86 | P/E | N/A | |||
| Day Low | $2.75 | EPS | $ | |||
| Volume | 638,399 | |||||
| (NASDAQ: NCEL) | Delayed: 3.30 -0.08 (2.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.38 | 52 Week High | $ | |||
| Open | $3.30 | 52 Week Low | $ | |||
| Day High | $3.32 | P/E | N/A | |||
| Day Low | $3.22 | EPS | $ | |||
| Volume | 3,750 | |||||

